EN
HI
Summary
As of 1 Sep, 2026, Sandu Pharmaceuticals stock price is ₹37.75. During the trading session, the stock has moved between an intraday low of ₹36.06 and an intraday high of ₹38.60. Over the last 52 weeks, Sandu Pharmaceuticals has traded between ₹30.00 and ₹50.50.
The stock has recorded a trading volume of 1,824 shares, with a market capitalization of ₹9660990. Its Average Traded Price (ATP) is ₹37.50, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹37.75.
Sandu Pharmaceuticals has an upper circuit limit of ₹45.84 and a lower circuit limit of ₹30.56. The total value traded stands at ₹68400.00, and the delivery percentage for the day is 56.63%.
The stock is currently traded with a market lot size of 1. Sandu Pharmaceuticals also offers a dividend yield of 2.62%.
Sandu Pharmaceuticals share price chart
Sandu Pharmaceuticals Share Key Metrics
Volume
1824.00
Market Cap
36.46 CR
LTQ@LTP
10@37.75
ATP
37.5
Var Margin
25 %
Circuit Range
30.56-45.84
Delivery %
56.63 %
Value
68400.00
ASM/GSM
No
Market Lot
1
Sandu Pharmaceuticals Fundamentals
P/E Ratio
23.78
P/B Ratio
1.1
Div. Yield
2.62
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Sandu Pharmaceuticals Resistance and Support
Pivot 37.92
Resistance
First Resistance
38.79
Second Resistance
39.37
Third Resistance
40.24
Support
First Support
37.34
Second Support
36.47
Third Support
35.89
Sandu Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 31 2026 | 38.6 | 37.75 | -1.18% | 38.6 | 36.06 |
| Fri Aug 28 2026 | 38.5 | 38.2 | 3.02% | 38.5 | 37.04 |
| Thu Aug 27 2026 | 38.4 | 37.08 | -0.32% | 38.4 | 36 |
Sandu Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-07-11 | Others |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-10-14 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-12 | Quarterly Results & Final Dividend |
Sandu Pharmaceuticals News
Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sandu Pharmaceuticals' 41st Annual General Meeting (AGM) is scheduled for September 11, 2026, at 04:30 PM via electronic mode. Key agenda item includes considering the Board's recommendation of a Rs.1.00 dividend per equity share for FY26.
Aug 14 2026 12:24:29
Sandu Pharmaceuticals Ltd - 524703 - Approval Of Material Related Party Transactions Subject To Approval Of Shareholders
Sandu Pharma's board approved Q1 FY27 standalone financial results, with revenue of Rs.16.39 cr and net profit of Rs.0.23 cr. The board also recommended a new statutory auditor and related party transactions, and fixed September 4, 2026, as the record date for the FY26 dividend.
Aug 11 2026 18:41:49
Read More
Sandu Pharmaceuticals Management
| Name | Position |
|---|---|
| Balram Viswanathan | Chairman & Non Executive Independent Director |
| Ajit R Kantak | Non Executive Independent Director |
Sandu Pharmaceuticals Similar Stocks
Sandu Pharmaceuticals FAQs
The Buying Price of Sandu Pharmaceuticals share is 37.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sandu Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sandu Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sandu Pharmaceuticals shares is 23.78. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sandu Pharmaceuticals shares is 1.1. Useful to assess the stock's value relative to its book value.
To assess Sandu Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sandu Pharmaceuticals is 36.46 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sandu Pharmaceuticals share price is 50.50 & 30.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sandu Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
